CMO Patheon is investing in a U.K. site to increase capacity and add capabilities, including automated capsule filling. The expansion comes as Patheon prepares to merge with DSM's pharma business under the ownership of JLL Partners. This week Patheon filed preliminary results for what could be its last full year as a public company. The Canada-based CMO posted an operating loss of $38.5 million. Release | More